Amgen (AMGN) Tops Q2 EPS by 10c; Boosts FY16 Outlook
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $361.33 -0.22%
Revenue Growth %: +2.6%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
CRMT, FOMI, FLES, More
Revenue Growth %: +2.6%
Financial Fact:
Total operating expenses: 3.28B
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $2.84, $0.10 better than the analyst estimate of $2.74. Revenue for the quarter came in at $5.69 billion versus the consensus estimate of $5.58 billion.
GUIDANCE:
Amgen sees FY2016 EPS of $11.10-$11.40. Amgen sees FY2016 revenue of $22.5-22.8 billion. The Street sees EPS of $11.18 and revenue of $22.57 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- Global-e completes $350M acquisition of Passport logistics firm
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
